Literature DB >> 26100912

Structural dynamics and energetics underlying allosteric inactivation of the cannabinoid receptor CB1.

Jonathan F Fay1, David L Farrens2.   

Abstract

G protein-coupled receptors (GPCRs) are surprisingly flexible molecules that can do much more than simply turn on G proteins. Some even exhibit biased signaling, wherein the same receptor preferentially activates different G-protein or arrestin signaling pathways depending on the type of ligand bound. Why this behavior occurs is still unclear, but it can happen with both traditional ligands and ligands that bind allosterically outside the orthosteric receptor binding pocket. Here, we looked for structural mechanisms underlying these phenomena in the marijuana receptor CB1. Our work focused on the allosteric ligand Org 27569, which has an unusual effect on CB1-it simultaneously increases agonist binding, decreases G--protein activation, and induces biased signaling. Using classical pharmacological binding studies, we find that Org 27569 binds to a unique allosteric site on CB1 and show that it can act alone (without need for agonist cobinding). Through mutagenesis studies, we find that the ability of Org 27569 to bind is related to how much receptor is in an active conformation that can couple with G protein. Using these data, we estimated the energy differences between the inactive and active states. Finally, site-directed fluorescence labeling studies show the CB1 structure stabilized by Org 27569 is different and unique from that stabilized by antagonist or agonist. Specifically, transmembrane helix 6 (TM6) movements associated with G-protein activation are blocked, but at the same time, helix 8/TM7 movements are enhanced, suggesting a possible mechanism for the ability of Org 27569 to induce biased signaling.

Entities:  

Keywords:  CB1; GPCR; allosteric; biased signaling; protein dynamics

Mesh:

Substances:

Year:  2015        PMID: 26100912      PMCID: PMC4500223          DOI: 10.1073/pnas.1500895112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Conformational changes in the G protein Gs induced by the β2 adrenergic receptor.

Authors:  Ka Young Chung; Søren G F Rasmussen; Tong Liu; Sheng Li; Brian T DeVree; Pil Seok Chae; Diane Calinski; Brian K Kobilka; Virgil L Woods; Roger K Sunahara
Journal:  Nature       Date:  2011-09-28       Impact factor: 49.962

2.  The magnitude of the light-induced conformational change in different rhodopsins correlates with their ability to activate G proteins.

Authors:  Hisao Tsukamoto; David L Farrens; Mitsumasa Koyanagi; Akihisa Terakita
Journal:  J Biol Chem       Date:  2009-06-04       Impact factor: 5.157

3.  Highly conserved tyrosine stabilizes the active state of rhodopsin.

Authors:  Joseph A Goncalves; Kieron South; Shivani Ahuja; Ekaterina Zaitseva; Chikwado A Opefi; Markus Eilers; Reiner Vogel; Philip J Reeves; Steven O Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

Review 4.  Refining efficacy: allosterism and bias in G protein-coupled receptor signaling.

Authors:  Louis M Luttrell; Terry P Kenakin
Journal:  Methods Mol Biol       Date:  2011

Review 5.  Diversity and modularity of G protein-coupled receptor structures.

Authors:  Vsevolod Katritch; Vadim Cherezov; Raymond C Stevens
Journal:  Trends Pharmacol Sci       Date:  2011-10-25       Impact factor: 14.819

6.  Conformational dynamics of helix 8 in the GPCR rhodopsin controls arrestin activation in the desensitization process.

Authors:  Kristina Kirchberg; Tai-Yang Kim; Martina Möller; Darko Skegro; Gayathri Dasara Raju; Joachim Granzin; Georg Büldt; Ramona Schlesinger; Ulrike Alexiev
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-28       Impact factor: 11.205

7.  Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum.

Authors:  G Griffin; E J Wray; B R Martin; M E Abood
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

8.  Distinct phosphorylation sites on the β(2)-adrenergic receptor establish a barcode that encodes differential functions of β-arrestin.

Authors:  Kelly N Nobles; Kunhong Xiao; Seungkirl Ahn; Arun K Shukla; Christopher M Lam; Sudarshan Rajagopal; Ryan T Strachan; Teng-Yi Huang; Erin A Bressler; Makoto R Hara; Sudha K Shenoy; Steven P Gygi; Robert J Lefkowitz
Journal:  Sci Signal       Date:  2011-08-09       Impact factor: 8.192

9.  Stabilized G protein binding site in the structure of constitutively active metarhodopsin-II.

Authors:  Xavier Deupi; Patricia Edwards; Ankita Singhal; Benjamin Nickle; Daniel Oprian; Gebhard Schertler; Jörg Standfuss
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-23       Impact factor: 11.205

10.  Crystal structure of the β2 adrenergic receptor-Gs protein complex.

Authors:  Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka
Journal:  Nature       Date:  2011-07-19       Impact factor: 49.962

View more
  19 in total

Review 1.  Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities.

Authors:  Leepakshi Khurana; Ken Mackie; Daniele Piomelli; Debra A Kendall
Journal:  Neuropharmacology       Date:  2017-05-17       Impact factor: 5.250

2.  Decay of an active GPCR: Conformational dynamics govern agonist rebinding and persistence of an active, yet empty, receptor state.

Authors:  Christopher T Schafer; Jonathan F Fay; Jay M Janz; David L Farrens
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-04       Impact factor: 11.205

3.  Molecular Dynamics Methodologies for Probing Cannabinoid Ligand/Receptor Interaction.

Authors:  Diane L Lynch; Dow P Hurst; Derek M Shore; Mike C Pitman; Patricia H Reggio
Journal:  Methods Enzymol       Date:  2017-07-04       Impact factor: 1.600

4.  Novel fluorescent GPCR biosensor detects retinal equilibrium binding to opsin and active G protein and arrestin signaling conformations.

Authors:  Christopher T Schafer; Anthony Shumate; David L Farrens
Journal:  J Biol Chem       Date:  2020-10-06       Impact factor: 5.157

Review 5.  Biased signalling: from simple switches to allosteric microprocessors.

Authors:  Jeffrey S Smith; Robert J Lefkowitz; Sudarshan Rajagopal
Journal:  Nat Rev Drug Discov       Date:  2018-01-05       Impact factor: 84.694

Review 6.  Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain.

Authors:  Samuel D Banister; Kaavya Krishna Kumar; Vineet Kumar; Brian K Kobilka; Sanjay V Malhotra
Journal:  Medchemcomm       Date:  2019-03-18       Impact factor: 3.597

7.  Angiotensin Analogs with Divergent Bias Stabilize Distinct Receptor Conformations.

Authors:  Laura M Wingler; Matthias Elgeti; Daniel Hilger; Naomi R Latorraca; Michael T Lerch; Dean P Staus; Ron O Dror; Brian K Kobilka; Wayne L Hubbell; Robert J Lefkowitz
Journal:  Cell       Date:  2019-01-10       Impact factor: 41.582

Review 8.  Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.

Authors:  David R Janero; Ganesh A Thakur
Journal:  Expert Opin Drug Discov       Date:  2016-10-21       Impact factor: 6.098

9.  Synthesis and biological evaluation of indole-2-carboxamides bearing photoactivatable functionalities as novel allosteric modulators for the cannabinoid CB1 receptor.

Authors:  Chang-Jiang Qiao; Hamed I Ali; Kwang H Ahn; Srikanth Kolluru; Debra A Kendall; Dai Lu
Journal:  Eur J Med Chem       Date:  2016-05-24       Impact factor: 6.514

10.  Structure of an allosteric modulator bound to the CB1 cannabinoid receptor.

Authors:  Zhenhua Shao; Wei Yan; Karen Chapman; Karthik Ramesh; Aaron J Ferrell; Jie Yin; Xuehui Wang; Qingping Xu; Daniel M Rosenbaum
Journal:  Nat Chem Biol       Date:  2019-10-28       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.